Abstract Non-Alcoholic Fatty Liver Disease (NAFLD) refers to the accumulation of lipid laden
vacuoles in hepatocytes, occurring in the context of visceral adiposity, insulin resistance and …

Background Data are scarce regarding the development of hepatic decompensation in
patients with non-alcoholic fatty liver disease (NAFLD) with and without type 2 diabetes. We …

Fatty liver plays a pivotal role in the pathogenesis of the metabolic syndrome and type 2
diabetes. According to an updated classification, any individual with liver steatosis and one …

Background We investigated the association between nonalcoholic fatty liver disease
(NAFLD) plus or minus a concurrent diagnosis of nonalcoholic steatohepatitis (NASH) and …

Background Social determinants of health (SDOH) are becoming increasingly recognised as
mediators of human health. In the setting of metabolic dysfunction‐associated steatotic liver …

Abstract Background and Aims Exercise training is recommended for all patients with
metabolic dysfunction‐associated steatotic liver disease and may reverse liver fibrosis …

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of abnormal liver
function tests worldwide, with an estimated prevalence ranging between 19–46% in the …

Metabolic dysfunction-associated steatotic (fatty) liver disease (MASLD), previously termed
non-alcoholic fatty liver disease, is a worldwide epidemic that can lead to hepatic …

Nonalcoholic fatty liver disease (NAFLD) represents a significant health threat worldwide.
The aging population and a rise in metabolic syndrome in Asia might influence the …

Metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed non-
alcoholic fatty liver disease (NAFLD), is defined as steatotic liver disease (SLD) in the …